Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Free Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Solid Biosciences (SLDB) Amortizatization of Intangibles: 2017-2024

Historic Amortizatization of Intangibles for Solid Biosciences (SLDB) over the last 6 years, with Dec 2024 value amounting to $803,000.

  • Solid Biosciences' Amortizatization of Intangibles fell 30.23% to $803,000 in Q4 2024 from the same period last year, while for Dec 2024 it was $3.6 million, marking a year-over-year increase of 49.17%. This contributed to the annual value of $3.6 million for FY2024, which is 49.17% up from last year.
  • According to the latest figures from Q4 2024, Solid Biosciences' Amortizatization of Intangibles is $803,000, which was down 33.53% from $1.2 million recorded in Q3 2024.
  • In the past 5 years, Solid Biosciences' Amortizatization of Intangibles registered a high of $1.2 million during Q3 2024, and its lowest value of -$582,000 during Q4 2021.
  • Moreover, its 3-year median value for Amortizatization of Intangibles was $408,000 (2022), whereas its average is $480,583.
  • Per our database at Business Quant, Solid Biosciences' Amortizatization of Intangibles tumbled by 101.15% in 2020 and then skyrocketed by 5,688.24% in 2023.
  • Over the past 5 years, Solid Biosciences' Amortizatization of Intangibles (Quarterly) stood at -$1,000 in 2020, then reached -$582,000 in 2021, then spiked by 147.42% to $276,000 in 2022, then spiked by 317.03% to $1.2 million in 2023, then slumped by 30.23% to $803,000 in 2024.
  • Its Amortizatization of Intangibles stands at $803,000 for Q4 2024, versus $1.2 million for Q3 2024 and $1.0 million for Q2 2024.